Announcements Trials
Browse Landscape

Status

Completed 20Recruiting 12Unknown 5Withdrawn 2Terminated 1Suspended 1Not yet recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 37Breast 5Gastrointestinal 3Thoracic 2Other hematologic neoplasm 2Lymphoid 2Gynecologic 2Dermatologic 2NET 1Head & Neck 1Endocrine 1CNS 1

Conditions

Neuroendocrine Tumors 5Pheochromocytoma 4Pituitary Neoplasms 3Paraganglioma 3Multiple Endocrine Neoplasia Type 1 3Hyperaldosteronism 2Epilepsy 2Diabetes Mellitus 2Carcinoma, Neuroendocrine 2Breast Neoplasms 2Adrenal Gland Neoplasms 2von Willebrand Disease, Type 3 1beta-Thalassemia 1Xanthomatosis, Cerebrotendinous 1X-Linked Combined Immunodeficiency Diseases 1Wolman Disease 1Waardenburg syndrome type 2A 1Waardenburg syndrome type 2 1Waardenburg Syndrome 1VLCAD deficiency 1Usher syndrome, type 1F 1Usher syndrome, type 1C 1Usher syndrome, type 1B 1Tyrosinemias 1Tuberous Sclerosis 2 1Tuberous Sclerosis 1 1Trifunctional Protein Deficiency With Myopathy And Neuropathy 1Thyroid Neoplasms 1Thyroid Dyshormonogenesis 6 1Thyroid Dyshormonogenesis 5 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Prostatic Neoplasms × Endocrine × Clear all
NCT05160480 2026-03-10

A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG

University of California, Davis

Enrolling by invitation
9 enrolled
BreastEndocrineGenitourinaryNET

Breast Neoplasms, Prostatic Neoplasms, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡